期刊
NATURE GENETICS
卷 45, 期 3, 页码 285-289出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2526
关键词
-
资金
- Brain Science Foundation
- Pediatric Low-Grade Astrocytoma Foundation
- American Brain Tumor Association
- Conquer Cancer Foundation Young Investigator Award
- US National Institutes of Health (NIH) [K08 CA122833, K08 NS064168, K12 CA090354-11]
- US Department of Defense grant [W81XWE-12-1-0136]
Meningiomas are the most common primary nervous system tumor. The tumor suppressor NF2 is disrupted in approximately half of all meningiomas(1), but the complete spectrum of genetic changes remains undefined. We performed whole-genome or whole-exome sequencing on 17 meningiomas and focused sequencing on an additional 48 tumors to identify and validate somatic genetic alterations. Most meningiomas had simple genomes, with fewer mutations, rearrangements and copy-number alterations than reported in other tumors in adults. However, several meningiomas harbored more complex patterns of copy-number changes and rearrangements, including one tumor with chromothripsis. We confirmed focal NF2 inactivation in 43% of tumors and found alterations in epigenetic modifiers in an additional 8% of tumors. A subset of meningiomas lacking NF2 alterations harbored recurrent oncogenic mutations in AKT1 (p.Glu17Lys) and SMO (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. These mutations were present in therapeutically challenging tumors of the skull base and higher grade. These results begin to define the spectrum of genetic alterations in meningiomas and identify potential therapeutic targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据